![](/img/cover-not-exists.png)
A phase I study of the antibody drug conjugate ASG-5ME, an SLC44A4-targeting antibody carrying auristatin E, in metastatic castration-resistant prostate cancer
McHugh, Deaglan, Eisenberger, Mario, Heath, Elisabeth I., Bruce, Justine, Danila, Daniel C., Rathkopf, Dana E., Feldman, Jarett, Slovin, Susan F., Anand, Banmeet, Chu, Rong, Lackey, Jacqueline, Reyno,Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-019-00731-5
Date:
February, 2019
File:
PDF, 683 KB
english, 2019